[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Phreesia, Inc. (PHR) shows a proposed sale of 3,133 common shares with an aggregate market value of $72,950.03. The shares were acquired on 09/11/2025 through restricted stock vesting and payment classified as compensation. The planned sale date is 09/16/2025 on the NYSE. The filer reported a prior sale within three months: 1,245 shares sold on 07/17/2025 for $33,472.82. The filing lists total outstanding shares as 59,914,473. Several standard identifying fields (issuer address, filer CIK/CCC, and named filer contact) are not provided in the visible content.

Positive

• Transaction disclosure includes acquisition date, nature (restricted stock vesting), sale date, broker, and aggregate value
• Three‑month sales history provided (1,245 shares sold on 07/17/2025 for $33,472.82), meeting disclosure requirements

Negative

• Key identifying fields missing in the provided excerpt (filer CIK/CCC and issuer name/address/contact information are not shown)
• Limited context: filing contains only securities sale details and attestation; no operational or financial information about the issuer is included

Insights

Financial Analyst

TL;DR: Routine insider sale tied to recently vested restricted stock; size is negligible relative to outstanding shares.

The filing documents a proposed sale of 3,133 common shares acquired by restricted stock vesting and classified as compensation. At an aggregate value of $72,950.03, this represents roughly 0.0052% of the reported 59,914,473 shares outstanding, indicating the transaction is immaterial to capitalization metrics. A prior sale of 1,245 shares on 07/17/2025 for $33,472.82 is disclosed, satisfying the three‑month sales history requirement. There are no earnings or operational details in this filing to reassess company fundamentals.

Compliance/Risk Analyst

TL;DR: Filing appears to satisfy Rule 144 disclosure elements but lacks some issuer/filer identifiers in the provided excerpt.

The notice includes required transaction details: class, number of shares, acquisition date, nature of acquisition (restricted stock vesting), sale date, broker, and recent three‑month sales. However, the provided content omits specific filer identification fields (CIK/CCC) and issuer contact/address information, which are typically present on a complete Form 144. The signer declares no undisclosed material adverse information, consistent with the form's attestation language.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3133	72950.03	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			3133	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alison C. Hoffman 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	1245	33472.82

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PHR Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 3,133 common shares of Phreesia (PHR) valued at $72,950.03, with an approximate sale date of 09/16/2025 on the NYSE.

How were the 3,133 shares acquired according to the filing?

The shares were acquired on 09/11/2025 through restricted stock vesting, and payment is classified as compensation.

Does the filing show any recent sales by the same person?

Yes. The filing reports a prior sale of 1,245 shares on 07/17/2025 with gross proceeds of $33,472.82.

What proportion of outstanding shares does this sale represent?

Based on the reported 59,914,473 shares outstanding, the 3,133 shares represent about 0.0052% of outstanding common shares.

Is the broker handling the sale identified?

Yes, the broker is listed as Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.